Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases—development and validation of the LabBM score

BACKGROUND: We aimed to investigate the potential of standard hematologic and serum biochemical parameters to provide an independent and substantial contribution to the prediction of survival in patients with newly diagnosed brain metastases (BM). METHODS: Hemoglobin, white blood cell count, platele...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Berghoff, Anna S, Wolpert, Fabian, Holland-Letz, Tim, Koller, Romina, Widhalm, Georg, Gatterbauer, Brigitte, Dieckmann, Karin, Birner, Peter, Bartsch, Rupert, Zielinski, Christoph C, Weller, Michael, Preusser, Matthias
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Clinical Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5570252/
https://ncbi.nlm.nih.gov/pubmed/28096493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now290
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares